| UCB S.A. |
| Belgien |
| Gesundheit |
| BE0003739530 / 852738 |
| UNC (Frankfurt) |
| FRA:UNC, ETR:UNC, UNC:GR |
| - |
| https://www.ucb.com/ |
|
UCB SA is a multinational biopharmaceutical company headquartered in Brussels, Belgium, founded in 1928 by Emmanuel Janssen. It specializes in developing innovative medicines for severe neurological and immunological diseases, including epilepsy, Par..
>Volltext.. |
| 40191.68 Mio. EUR |
| 42972.68 Mio. EUR |
| 8414.33 Mio. EUR |
| 3296.04 Mio. EUR |
| 2165.77 Mio. EUR |
| 11.38 EUR |
| 3541.84 Mio. EUR |
| 756.14 Mio. EUR |
| 1821.26 Mio. EUR |
| 0.18 |
| 24.47% |
| 64.71% |
| 1.45 EUR |
| 0.48% |
| 0.46% |
| 04.05.26 - 1.45€ 25.04.25 - 1.39€ >weitere anzeigen... |
| - |
| UCB |
| 16.08.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|